Israel - English - Ministry of Health

baxter healthcare distribution ltd., israel - glucose as monohydrate; sodium chloride - solution for infusion - sodium chloride 0.18 %w/v; glucose as monohydrate 4.00 %w/v - electrolytes with carbohydrates - sodium chloride 0.18 % and glucose 4% solution is used in the following indications:dehydration treatment due to a moderated loss of sodium and chloride (vomiting, diarrhoea, renal disorders, overuse ofdiuretics) in cases where a source of energy is required (particularly starvation).paediatric population:this product should only be used in paediatric specialist settings (such as renal, hepatic and cardiac units, highdependency units and intensive care units) for intravenous fluid therapy requiring the use of 0.18% sodium chloride and4% glucose to maintain fluid and electrolyte balance.

Malta - English - Medicines Authority

baxter healthcare limited - glucose, sodium chloride - solution for infusion - glucose 5 percent weight/volume ; sodium chloride 0.45 percent weight/volume - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - glucose, sodium chloride - solution for infusion - glucose 5 % (w/v) sodium chloride 0.45 % (w/v) - blood substitutes and perfusion solutions

Israel - English - Ministry of Health

baxter healthcare distribution ltd., israel - glucose as monohydrate - solution for infusion - glucose as monohydrate 10 % - carbohydrates - as intravenous injection: glucose 10% baxter is indicated as a source of water and calories. as parenteral nutrient: glucose 10% baxter is indicated as a caloric component in parenteral nutrition regimen. it is used with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1) the alimentary tract cannot should not be used. 2) gastrointestinal absorption of protein is impaired, or 3) metabolic requirements for protein are substantially increased, as extensive burns

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - glucose monohydrate 55 g/l;   - solution for infusion - 5 % - active: glucose monohydrate 55 g/l   excipient: hydrochloric acid sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glucose monohydrate 5% - solution for infusion - 5 % - active: glucose monohydrate 5% - isotonic (glucose 5%) infusion solutions are mainly indicated for: - whenever non-electrolyte fluid replacement is required, - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

Israel - English - Ministry of Health

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; calcium chloride dihydrate; glucose monohydrate; glucose monohydrate; magnesium chloride hexahydrate; magnesium chloride hexahydrate; sodium chloride; sodium chloride; sodium hydrogen carbonate; sodium hydrogen carbonate - solution for peritoneal dialysis - sodium chloride 11.57 g/l; calcium chloride dihydrate 0.5145 g/l; magnesium chloride hexahydrate 0.2033 g/l; glucose monohydrate 25.0 g/l; magnesium chloride hexahydrate 0.1017 g/l; calcium chloride dihydrate 0.2573 g/l; sodium hydrogen carbonate 2.940 g/l; sodium chloride 5.786 g/l; sodium hydrogen carbonate 5.880 g/l; glucose monohydrate 50.00 g/l - combinations of electrolytes - combinations of electrolytes - end-stage (decompensated ) chronic renal failure of any origin treated with peritoneal dialysis.17/10/2017 בקשה לשינוי משטר מינון שינוי משטר מינון בהתאם למאושר באירופה

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; glucose monohydrate, quantity: 25 g/l (equivalent: glucose, qty 22.7 g/l); calcium chloride dihydrate, quantity: 0.184 g/l; sodium chloride, quantity: 5.38 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 10 percent weight/volume - solutions for parenteral nutrition; carbohydrates

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 10 percent weight/volume - solutions for parenteral nutrition; carbohydrates